(Q46762726)

25 December 2017

editorial

0 references

title

Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection? (English)

1 reference

25 December 2017

author

Hazel Dockrell

series ordinal

1

1 reference

25 December 2017

author name string

Steven G Smith

series ordinal

2

1 reference

25 December 2017

Maeve K Lalor

series ordinal

3

1 reference

25 December 2017

publication date

1 February 2012

1 reference

25 December 2017

Expert Review of Vaccines

published in

1 reference

25 December 2017

volume

11

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

121-124

1 reference

25 December 2017

Fact and fiction in tuberculosis vaccine research: 10 years later

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Immunological footprint: the development of a child's immune system in environments rich in microorganisms and parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

Microbiota–immune system interaction: an uneasy alliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.186

21 January 2018

Identifiers

DOI

10.1586/ERV.11.186

1 reference

25 December 2017

1 reference

25 December 2017